RECRUITING

Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia

Description

This is a small-scale micro-randomized clinical trial of a new mobile just-in-time adaptive intervention (JITAI) designed to promote oral chemotherapy adherence in adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL). The goals of this study are to determine intervention feasibility and acceptability.

Conditions

Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma
Talk to us

Related Conditions:

Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma

Study Overview

On this page

Study Details

Study overview

This is a small-scale micro-randomized clinical trial of a new mobile just-in-time adaptive intervention (JITAI) designed to promote oral chemotherapy adherence in adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL). The goals of this study are to determine intervention feasibility and acceptability.

Using Real Time Mobile Health Approaches to Understand and Promote Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia

Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia

Condition
Acute Lymphoblastic Leukemia
Intervention / Treatment

-

Contacts and Locations

Chicago

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States, 60611

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Ages 14-29
  • * Diagnosed with acute lymphoblastic leukemia (ALL) or lymphoma
  • * In the maintenance phase, completed at least one cycle and has at least one month of maintenance therapy remaining.
  • * Prescribed 6-mercaptopurine (6MP)
  • * English language proficiency
  • * For AYA \<18, must have informed consent from their caregiver.
  • * Cognitive impairments that would limit ability to complete measures, determined by the medical team
  • * Absence of inclusion criteria above.

Ages Eligible for Study

14 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Northwestern University,

Alexandra M Psihogios, Ph.D., PRINCIPAL_INVESTIGATOR, Northwestern University

Study Record Dates

2026-08-31